years ago with the use of exogenous gonadotrophins. 7 The introduction of invitro fertilization & embryo transfer (IVF-ET) in 1980s has made it possible for the couple to take advantage of this technology. 7 Controlled ovarian hyper stimulation combined with IUI of capacitated sperm (COH-IUI) has recently been used to treat a subset of couples infertile in the absence of mechanical compromise of the pelvic viscera, in whom no other efficacious treatment options exist . 8, 9, 10 . The major difference of COH-IUI with IVF is that the normal fallopian tubes can be anticipated to function appropriately and no surgical procedure is required to collect oocytes. 8, 9, 10 The benefit of IUI in male factor infertility has been accepted because IUI appears to result in higher pregnancy rates than natural intercourse or Intra Cervical Insemination (OR 2.20, 95% CI 1.43-3.39). 11 In a review, Hammburg and Insler 12 concluded that, taking into account efficacy, complication rates and cost of infertility treatment women with hypogonadotrophic hypogonadism or polycystic ovary syndrome (PCOS) should be offered acceptable methods of ovulation induction and that couples with 'unexplained' or 'multifactorial subfertility' should be exposed to controlled ovarian hyperstimulation with IUI (COH IUI) and only after the failure of these therapies should be offered invitro fertilization (IVF). 12 For COH in IUI cycles, ovulation induction protocols are Clomiphene citrateCc, Aromatase inhibitor (Letrozole) alone or in combination with Gonadotrophins (hMG or rFSH), human chorionic Gonadotrophins (hCG); and the use of GnRH agonist or antagonist combined with Gonadotrophins. hCG is usually used at the end of the stimulation phase to achieve final maturation of the oocytes. 13 The addition of IUI to Letrozole increase fecundity in couples with unexplained infertility or surgically treated endometriosis. 14, 15 . Ovarian stimulation with letrozole is associated with acceptable pregnancy rates compared with gonadotrophin (cumulative pregnancy rate per couple: 24% vs. 36%), 16 with significant less cost, risk and patient inconvenience.
The combination of IUI with gonadotrophin and letrozole stimulation provides even better results than the combination of IUI with clomiphene. 17 
Materials and Methods:
This study was conducted at Centre for Assisted Reproduction (CARE), BIRDEM, Dhaka, during the period of 10 th May to 31 st December, 2010. All the infertility patients who were selected for IUI from CARE OPD BIRDEM were included in this study. Informed consent were taken from the couples and interviewed by a structured questionnaire Inclusion criteria: The female patients with age <40 yrs, history of infertility for at least 2 yrs and with either of the following problems (unexplained infertility, polycystic ovarian syndrome, mild endometriosis) were included. Males with mild to moderate male factor sub fertility with total count (>10 million/ml), motility grade A (> 10%), morphology (>30% N) and erectile dysfunction or hypospadias were included.
Exclusion criteria: Female with bilateral tubal block, severe endometriosis and no ovarian reserve, and male with sperm count <10 million / ml were excluded.
Variables of the study:
Input variable: Type and dose of ovulation inducing agent Output variable: Follicular size, endometrial thickness, pregnancy outocme Study Procedure: The patients were divided in to two groups. Group A: Female with young age < 30 years, and Group B: Female with age >30 years.
Superovulation Protocol:
Both groups of patients were stimulated by Letrozole 7.5 mg daily, started on D2 of the cycle and continued for 5 days. Patients were followed by this treatment for 3 cycles of IUI. Follicular response was assessed by TVS on D12 -13, when at least two follicles attained >18 mm size or single follicle >21 mm size then it was considered satisfactory.This treatment was followed for 3 cycles. The patients who did not respond satisfactorily by 3 cycles of Letrozole were selected for combination of Letrozole and Gonadotrophins. These patients were stimulated by Inj. Gonadotrophins (rFSH 50 iu/ inj. hMG 75 iu) intra muscularly daily starting from D3 for 5-7 days + Letrozole 7.5 mg per day on D 2 -D 6 . Patients were followed up byTVS on D12/D13 (follicular size, number and endometrial thickness).In both regims when follicles attain satisfactory size, Inj. HCG (pregnyl/professy) 5000 IUI was given intra muscularly. A single IUI insemination was performed 36 hours after the Inj. of hCG .
Main outcome measure: Number of the follicle 2-3, Size of the follicle >18 mm and Endometrial thickness > 8 mm was considered as satisfactory.
Definition of Pregnancy:
Patients were asked to attend the OPD of CARE BIRDEM 15 days after the missed period. Positive pregnancy test result was defined as pregnancy. Pregnant patients were advised to come for regular antenatal checkup.
Data processing & analysis: Result of the study was analyzed by standard statistical methods by using SPSS (Statistical Package for Social Science) software, version 16 (SPSS, Inc. Chicago, IL, USA) and Excel windows programme. The data was expressed as mean±SD and median (range) as appropriate. Student's unpaired t-test was used for calculating the difference between the groups. ÷2 (chi square) test was performed to determine the clustering of different variable of interest. P value of less than 0.05 was considered statistically significant. In >30 yrs group, only 5 (13%) patients had mature follicles, whereas in <30 yrs 8 (22%) patients had mature follicles. P value is 0.74, which is not significant. In >30 yrs age group, 30 (88%) patients had mature follicles, whereas in <30 yrs age group, 20 (66%) patients had mature follicles.P is 0.2. COH and IUI are common treatments for couples with unexplained infertility and those with infertility associated with specific diagnoses in which no pregnancy has occurred despite standard directed treatments. Total 77 patients were selected for IUI in our centre CARE BIRDEM. All patients had some sort of past infertility treatment, at various levels from various parts of the country. In the present study, mean age of female patient was 31±4.8 yrs. The mean duration of infertility was 9.5±4.6 yrs. 18 who showed ovulatory rate by letrozole was 75% and 87.5%, respectively. Another study by Mitwally 15 showed that treatment with letrozole+ FSH required less amount of FSH (616 IU vs. 1590 IU) than FSH alone , and the number of follicle >18mm was higher, in combined letrozole and FSH group (3.3 vs. 1.9, respectively) which is consistent with our study (3.37±0.87 vs. 1.28±0.94).
Observation and result:
Another study comparing 3 treatment protocols letrozole+ FSH, CC+FSH and FSH only in patients with unexplained infertility undergoing COH and IUI by Mitwally 14 showed that the total FSH dose was lowest in letrozole+ FSH group, but the endometrial thickness was highest in the letrozole+ FSH group (9mm). The clinical pregnancy rate was highest in letrozole+ FSH group (22.2%) which is comparable with our study, where pregnancy rate is 14.3% in combined letrozole and gonadotrophins group. The results of this study suggest that the addition of letrozole to FSH can reduce the dose of FSH and medication expense without detrimental effects on endometrial thickness and pregnancy.
In another study by Rumste 19 regarding COS and IUI in unexplained infertility showed that 32% of the couples conceived in four treatment cycles of COS-IUI which is within the range of 20-33% reported by others (Guzick et al. 20 ). In other literatures by Crosignani 21 , Guzick et al. 20 , Dickey et al. 22 pregnancy rate per cycle has been reported to vary from 9-20%. It has been shown that increasing maternal age, longer duration of non-conception and a poor semen quality have a negative impact on the pregnancy rate in couples receiving COS-IUI (Dickey et al. 2002 22 ) . Multifollicular growth contains the risk of multiple pregnancies. Another study by Sarah Healey et al 23 about the effect of letrozole and gonadotrophins in IUI patients showed that they required less gonadotrophin administration (median difference, 300 IU at 95% CI, 225-375 IU) and had a thinner endometrium, (m df 1 mm), developed more follicles >14 mm (m df, 1 follicle 95% CI, 1-2 follicle). But the pregnancy rate did not differ between patients using gonadotrophins alone and those using gonadotrophins+ letrozole (20.9% vs. 21.6%). Between two age groups, in >30 yrs group, only 5 (13%) patients had mature follicles, whereas in <30 yrs 8 (22%) patients had mature follicles. P value is 0.74, which is not significant. Ovulatory cycle was 28/111 cycles, in <30 yrs age group, and 17/120 cycles, in >30 yrs age group. P is 0.051 which is not significant. Pregnancy rate/cycle was 9/111 cycles in <30 yrs age group, and 3/120 cycles in >30 yrs age group. P value is 0.11, which is not significant. Thus there is no statistical significance in follicular response and pregnancy rate by giving letrozole alone in these two groups.
65 patients were poor responders to letrozole were treated with combined letrozole and gonadotrophins. In >30 yrs age group, 31 (86%) out of 35 patients had mature follicles, whereas in <30 yrs age group, 20 (66%) out of 30 patients had mature follicles. P value is 0.2, which is not significant. Therefore there is no significant difference in follicular response between two age groups by gonadotrophins. But >30 yrs age group required more doses of gonadotrophin (avg of 5-7 doses) than <30 yrs age group.
There is no known national or international study regarding the follicular response of different age groups. There is no national study regarding the controlled ovarian stimulation and IUI, with which to compare.
Conclusion:
Infertility definitely has some tragic dimensions in the family life of many couples. The cause of infertility varies from country to country and in different social groups. Endometriosis, PCOS and male factor are common cause in developed countries, whereas STDs are the main cause in African countries. Incidence of tubal occlusion in our country can be prevented by safe delivery, safe abortion and post abortal care and increasing the awareness about infertility. For PCOS resistant to clomiphene or letrozole, mild endometriosis, unexplained infertility and also mild to moderate male factor infertility, the combination of superovulation and intrauterine insemination is an effective measure for achieving pregnancy. Moreover the effects of superovulation and IUI appear to be independent and additive. IUI and COH is relatively simple, non-invasive, inexpensive and effective measure. It can be provided more easily to more infertile couples in office practices and general hospitals than can the more specialized techniques such as IVF. However, careful selection of patients is required for successful IUI. Studies by Goverde et al. 24 on cost effectiveness of IUI and COH showed that it was as effective as IVF in achieving pregnancy (31% vs. 33%) and was more cost effective than IVF. So these two groups of patients should be counselled that IUI and COH is their preferable method, and there is least chance of complications like hyperstimulation syndrome, multiple pregnancy. Many infertile couples of today may have new hope for future days that science will continue to unravel the mysteries of procreation and with the discovery of each mystery more infertile couples will enjoy the fulfilment of bearing a child. 
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